A Cost-Benefit Analysis of Immunization for Pneumococcal Pneumonia
作者： Kevin M. Patrick
DOI: 10.1001/JAMA.1981.03310300027014
关键词:
摘要: To determine whether immunization against pneumococcal pneumonia could be justified on the basis of a favorable benefit to cost ratio, we evaluated projected impact program vaccination population health maintenance organization. Retrospective data average provider and patient costs associated with episodes were coupled forecasts likely effectiveness currently available vaccine its anticipated incidence pneumonia. We found that when provider-centered patient-centered benefits added, immunizing those traditionally considered at high risk contracting (50 years age older; patients chronic diseases heart, liver, lungs, or kidneys; diabetes mellitus) was cost-benefit basis. ( JAMA 1981;245:473-477)
sci-hub.se 参考文章(14)
Koornhof Hj, Hayden-Smith S, Reid Rd, Douglas Rm, Coetzee Am, Austrian R, Schiffman G, Prevention of pneumococcal pneumonia by vaccination. Transactions of the Association of American Physicians. ,vol. 89, pp. 184- 194 ,(1976)
R. E. Weibel, P. P. Vella, A. A. McLean, A. F. Woodhour, W. L. Davidson, M. R. Hilleman, Studies in Human Subjects of Polyvalent Pneumococcal Vaccines Experimental Biology and Medicine. ,vol. 156, pp. 144- 150 ,(1977) , 10.3181/00379727-156-39894
Smith Ha, Steiner Kc, Application of cost-benefit analysis to a PKU screening program. Inquiry : a journal of medical care organization, provision and financing. ,vol. 10, pp. 34- 40 ,(1973)
B Wentworth, J M Kloeck, H M Foy, G E Kenny, J T Grayston, Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group. The American review of respiratory disease. ,vol. 111, pp. 595- 603 ,(1975) , 10.1164/ARRD.1975.111.5.595
William M. Valenti, Martin Jenzer, David W. Bentley, Type-Specific Pneumococcal Respiratory Disease in the Elderly and Chronically III1–4 The American review of respiratory disease. ,vol. 117, pp. 233- ,(1978) , 10.1164/ARRD.1978.117.2.233
Allen B. Kaiser, Prospectus: The Prevention of Bacteremic Pneumococcal Pneumonia JAMA. ,vol. 230, pp. 404- 408 ,(1974) , 10.1001/JAMA.1974.03240030022019
D P Rice, B S Cooper, The economic value of human life. American Journal of Public Health and the Nations Health. ,vol. 57, pp. 1954- 1966 ,(1967) , 10.2105/AJPH.57.11.1954
Jeffrey P. Koplan, Stephen C. Schoenbaum, Milton C. Weinstein, David W. Fraser, Pertussis Vaccine — An Analysis of Benefits, Risks and Costs New England Journal of Medicine. ,vol. 301, pp. 906- 911 ,(1979) , 10.1056/NEJM197910253011703
Edward W. Saitz, Pneumococcal Pneumonia JAMA. ,vol. 239, pp. 2372- 2372 ,(1978) , 10.1001/JAMA.1978.03280490056027
R. Austrian, Random Gleanings from a Life with the Pneumococcus The Journal of Infectious Diseases. ,vol. 131, pp. 474- 484 ,(1975) , 10.1093/INFDIS/131.4.474